Bayer : Volker Koch-Achelpöhler to head Bayer’s EU Liaison Office in Brussels -- Predecessor Bernd Halling to assume a global role at Group headquarters

Leverkusen/Brussels, January 9, 2017- Bayer has appointed a new head of its EU Liaison Office in Brussels, Belgium, effective February 1, 2017. Volker Koch-Achelpöhler (52), currently Director General of the German Crop Protection and Fertilizer Association (IVA) in Frankfurt, will take over this role and represent Bayer's position on all political issues at the various EU institutions.

Prior to his almost 11-year service with the IVA, Koch-Achelpöhler had already worked in Brussels as an industry association representative. He therefore has many years of experience providing policy advice, especially in respect of agricultural policy.

After more than eight years in Brussels, his predecessor as head of the EU Liaison Office, Bernd Halling (47), will transfer to Bayer's headquarters in Leverkusen, where he will head the Corporate Policy and Strategy unit that is responsible for the company's global positioning on political lobbying issues. Both will report to the head of Public and Governmental Affairs within Communications and Public Affairs.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go towww.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website atwww.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.